Lupus nephritis: lessons from the path lab. (Q40758583)

23 September 2017

1 reference

title

Lupus nephritis: lessons from the path lab. (English)

1 reference

23 September 2017

1 reference

Kashgarian M

1

1 reference

PubMed ID

8196299

23 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

23 September 2017

1 reference

23 September 2017

45

1 reference

23 September 2017

3

1 reference

23 September 2017

928-938

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1994.123

23 September 2017

0 references

cites work

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The clinical course of the proliferative and membranous forms of lupus nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Prognostic factors in diffuse proliferative lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The lupus autoantigens and the pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Clinical significance of IgG subclasses of anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Activation of neutrophil phagocytosis of complement coated and IgG coated sheep erythrocytes by platelet release products

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Platelets mediate neutrophil-dependent immune complex nephritis in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Immunological studies concerning the nephritis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The immunopathology of SLE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Circulating DNA and lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The pathobiology of the mesangium

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Ultrastructural "fingerprint" in cryoprecipitate and glomerular deposits: a case report of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Human lupus inclusions and interferon

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Can experienced clinicians predict the outcome of lupus nephritis?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The time-dependence of long-term prediction in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The information content from renal biopsy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

The distribution and character of glomerular deposits in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Prognostic indices in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

A Randomized Trial of Plasmapheresis and Subsequent Pulse Cyclophosphamide in Severe Lupus: Design of the Lpsg Trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Histologic features that correlate with the prognosis of patients with lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.123

7 January 2021

Identifiers

DOI

10.1038/KI.1994.123

1 reference

23 September 2017

1 reference

PubMed ID

8196299